Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-20T04:05:29.577Z Has data issue: false hasContentIssue false
  • English
  • Français

Severe cardiac involvement in Gaucher type IIIC: a case report and review of the literature

Published online by Cambridge University Press:  10 April 2017

Yılmaz Kör ,
Mehmet Keskin  and
Osman Başpınar
Yılmaz Kör*
Affiliation:
Pediatric Endocrinology Division, Pediatrics Clinic, Adana Numune Training and Research Hospital, Adana, Turkey
Mehmet Keskin
Affiliation:
Department of Pediatric Endocrinology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
Osman Başpınar
Affiliation:
Department of Pediatric Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
*
Correspondence to: Y. Kör, Adana Numune Eğitim Araştırma Hastanesi, Çocuk Endokrinoloji Bölümü, Adana, Turkey. Tel: +90 322 3550101; Fax: +90 322 3550028; E-mail: dykor05@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Gaucher disease is an autosomal-recessive lysosomal storage disease characterised by the accumulation of glucocerebroside in macrophages; it is caused by mutations in glucocerebrosidase gene-1 in many organ tissues such as the liver, spleen, and bone marrow. Its different clinical subtypes, according to the presence and severity of neurological symptoms, are as follows: type I, non-neuronopathic (95%); type II, acute neuronopathic; and type III, chronic neuronopathic. Type IIIC is a rare subgroup characterised by cardiovascular involvement as well as eye-movement disorders and late-onset neurological symptoms. In such cases, homozygous D409H is the most frequently detected mutation. In this article, we report the case of a patient, aged 15 years and 8 months, with complaints of syncope and a diagnosis of type IIIC Gaucher disease.

Keywords

Gaucher diseaseheart valve diseasesapraxiasyncope
Type
Brief Report
Information
Cardiology in the Young , Volume 27 , Issue 7 , September 2017 , pp. 1426 - 1429
Check for updates
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Grabowski, GA, Petsko, GA, Kolodyn, EH. Lysosomal disorders: Gaucher disease. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson KM, Mitchell G (eds). The Metabolic & Molecular Bases of Inherited Diseases, 8th edn. McGraw-Hill, New York, 2001: 3635–3668.Google Scholar
2. Chabás, A, Cormand, B, Grinberg, D, et al. Unusual expression of Gaucher’s disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation. J Med Genet 1995; 32: 740–742.Google Scholar
3. Cogan, DG, Chu, FC, Reingold, D, Barranger, J. Ocular motor signs in some metabolic diseases. Arch Ophthalmol 1981; 99: 1802–1808.Google Scholar
4. Bohlega, S, Kambouris, M, Shahid, M, Al Homsi, M, Al Sous, W. Gaucher disease with oculomotor apraxia and cardiovascular calcification (Gaucher type IIIC). Neurology 2000; 54: 261–263.Google Scholar
5. Aabha, N. Gaucher disease. J Clin Exp Hepatol 2014; 4: 37–50.Google Scholar
6. Horowitz, M, Zimran, A. Genotype-phenotype correlation in Gaucher disease. In: Humphries SE, Malcolm S (eds). From Genotype to Phenotype. BIOS Scientific Publishers, Oxford, 1994: 67–81.Google Scholar

Kör supplementary material S1

Supplementary Video

Download Kör supplementary material S1(Video)
Video 857.2 KB
Supplementary material: File

Kör supplementary material S2

Supplementary Video

Download Kör supplementary material S2(File)
File 1.9 MB